Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Brian Branchford MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Hematology

Member of the Center for Immunology


Publications (73)

  • Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers. (Branchford B, Clark K, Stanford RH, Garner DA, Huang SP, Wolford E) Blood Coagul Fibrinolysis 2024 Apr 01;35(3):73-81 PMID: 38305129 PMCID: PMC10990012 SCOPUS ID: 2-s2.0-85189497878 02/02/2024    
  • Corrigendum to ' Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium' [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139]. (Wilson HP, Mosha M, Branchford B, Jaffray J, Krava E, Stillings A, Lebensburger J, Goldenberg NA) Res Pract Thromb Haemost 2023 Nov;7(8):102259 PMID: 38053986 PMCID: PMC10694757 SCOPUS ID: 2-s2.0-85177483181 12/06/2023    
  • Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium. (Abrams CM, Jaffray J, Stillings A, Branchford BR, Young G, Goldenberg NA, Abajas YL, CHAT Consortium Investigators, VTE Risk Factors and Thromboprophylaxis Working Group of the Pediatric and Neonatal Thrombosis and Hemostasis Subcommittee of the ISTH SSC, Fargo J, Crary S, Kumar R, Woods G, Narang S, Cooper J, Silvey M, Garland K, Mahajerin A, Luchtman-Jones L, Torres M, Wright J, Pahl K, Armstrong K, Braunreiter C, Bakeer N, Sochet A, Hogan M, Gupta S, Knoll C, Hege K, Schaefer B, Panigrahi A, Thornburg C, Shimano K, Ahuja S, Weyand A, Boucher A, Abajas Y, Subbaswamy A, Khan O, Druzgal C, Maida D, Wheeler A, Malec L, Branchford B, Kucine NE, Prozora S) Res Pract Thromb Haemost 2022 Oct;6(7):e12793 PMID: 38024326 PMCID: PMC10656282 SCOPUS ID: 2-s2.0-85142112093 11/29/2023    
  • Corrigendum to ‘ Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139] (Research and Practice in Thrombosis and Haemostasis (2023) 7(5), (S2475037923001899), (10.1016/j.rpth.2023.102139)) (Wilson HP, Mosha M, Branchford B, Jaffray J, Krava E, Stillings A, Lebensburger J, Goldenberg NA) Research and Practice in Thrombosis and Haemostasis November 2023;7(8) SCOPUS ID: 2-s2.0-85177483181 11/01/2023    
  • Hospital-Acquired Venous Thromboembolism and Invasive Mechanical Ventilation: A Report From the Children's Hospital Acquired Thrombosis Consortium. (Sochet AA, Jaffray J, Branchford BR, Havlicek EE, Mosha M, Amankwah EK, Ignjatovic V, Faustino EVS, Goldenberg NA) Pediatr Crit Care Med 2024 Feb 01;25(2):e82-e90 PMID: 37882641 PMCID: PMC10843146 SCOPUS ID: 2-s2.0-85182954678 10/26/2023    
  • Corrigendum to 'Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium' [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]. (Jaffray J, Mosha M, Branchford B, Goldenberg NA, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Amankwah EK) J Thromb Haemost 2023 Dec;21(12):3658 PMID: 37741798 SCOPUS ID: 2-s2.0-85171683467 09/24/2023    
  • Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium. (Wilson HP, Mosha M, Branchford B, Jaffray J, Krava E, Stillings A, Lebensburger J, Goldenberg NA) Res Pract Thromb Haemost 2023 Jul;7(5):102139 PMID: 37601027 PMCID: PMC10439380 SCOPUS ID: 2-s2.0-85164997292 08/21/2023    
  • Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium (Wilson HP, Mosha M, Branchford B, Jaffray J, Krava E, Stillings A, Lebensburger J, Goldenberg NA) Research and Practice in Thrombosis and Haemostasis July 2023;7(5) SCOPUS ID: 2-s2.0-85164997292 07/01/2023    
  • Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortium. (Jaffray J, Mosha M, Branchford B, Goldenberg NA, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Amankwah EK) J Thromb Haemost 2023 Sep;21(9):2441-2450 PMID: 37100395 SCOPUS ID: 2-s2.0-85160414884 04/27/2023       1 Citation
  • Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium (Silvey M, Nguyen ATH, Amankwah EK, McElwaine E, Branchford B, Stillings A, Krava E, Young G, Goldenberg N, Jaffray J) Thrombosis Research December 2022;220:116-120 SCOPUS ID: 2-s2.0-85140805433 12/01/2022       2 Citations
  • Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium. (Silvey M, Nguyen ATH, Amankwah EK, McElwaine E, Branchford B, Stillings A, Krava E, Young G, Goldenberg N, Jaffray J) Thromb Res 2022 Dec;220:116-120 PMID: 36334398 SCOPUS ID: 2-s2.0-85140805433 11/06/2022       2 Citations
  • Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium. (Stephens ET, Nguyen ATH, Jaffray J, Branchford B, Amankwah EK, Goldenberg NA, Faustino EVS, Zakai NA, Stillings A, Krava E, Young G, Fargo JH) Res Pract Thromb Haemost 2022 Oct;6(7):e12810 PMID: 36254253 PMCID: PMC9561357 SCOPUS ID: 2-s2.0-85141974381 10/19/2022    
  • Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium (Abrams CM, Jaffray J, Stillings A, Branchford B, Young G, Goldenberg NA, Abajas YL, Fargo J, Crary S, Kumar R, Woods G, Narang S, Cooper J, Silvey M, Garland K, Mahajerin A, Luchtman-Jones L, Torres M, Wright J, Pahl K, Armstrong K, Braunreiter C, Bakeer N, Sochet A, Hogan M, Gupta S, Knoll C, Hege K, Schaefer B, Panigrahi A, Thornburg C, Shimano K, Ahuja S, Weyand A, Boucher A, Abajas YL, Subbaswamy A, Khan O, Druzgal C, Maida D, Wheeler A, Malec L, Branchford B, Kucine NE, Prozora S) Research and Practice in Thrombosis and Haemostasis October 2022;6(7) SCOPUS ID: 2-s2.0-85142112093 10/01/2022    
  • Safety and Efficacy of Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Pediatric Oncology Patients. (Scheuermann A, Liegl M, Simpson P, Branchford B, Malec L) J Pediatr Hematol Oncol 2023 Jan 01;45(1):e65-e69 PMID: 36161995 SCOPUS ID: 2-s2.0-85145641530 09/27/2022       1 Citation
  • Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. (Woods GM, Raffini L, Brandão LR, Jaffray J, Branchford BR, Ng CJ, Sartain SE, Pak J, Male C, Zia A, Rizzi M, Sirachainan N, Faustino EVS, Carpenter SL, Goldenberg NA) J Thromb Haemost 2022 Sep;20(9):2151-2158 PMID: 35748322 SCOPUS ID: 2-s2.0-85134391924 06/25/2022    
  • Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength. (Jones WL, Ramos CR, Banerjee A, Moore EE, Hansen KC, Coleman JR, Kelher M, Neeves KB, Silliman CC, Di Paola J, Branchford B) Platelets 2022 Nov 17;33(8):1119-1131 PMID: 35659185 PMCID: PMC9547822 SCOPUS ID: 2-s2.0-85131577214 06/07/2022       6 Citations
  • Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium. (Jaffray J, Baumann Kreuziger L, Branchford B, Wee CP, Faustino EVS, Zakai NA, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Goldenberg NA) J Thromb Haemost 2022 Jan;20(1):133-137 PMID: 34623749 SCOPUS ID: 2-s2.0-85117177584 10/09/2021       8 Citations
  • A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children's Hospital-Acquired Thrombosis Consortium. (Jaffray J, Mahajerin A, Branchford B, Nguyen ATH, Faustino EVS, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Zakai NA, Stillings A, Krava E, Amankwah EK, Young G, Goldenberg NA) Pediatr Crit Care Med 2022 Jan 01;23(1):e1-e9 PMID: 34406168 PMCID: PMC8738123 SCOPUS ID: 2-s2.0-85123275047 08/19/2021       10 Citations
  • Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single-center report. (Warren BB, Chan A, Manco-Johnson M, Branchford BR, Buckner TW, Moyer G, Gibson E, Thornhill D, Wang M, Ng CJ) Res Pract Thromb Haemost 2021 Jul;5(5):e12571 PMID: 34377887 PMCID: PMC8331949 SCOPUS ID: 2-s2.0-85112348174 08/12/2021       10 Citations
  • Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center. (Ng CJ, Spomer N, Shearer R, LeBlanc A, Funk S, Manco-Johnson M, Branchford B, Warren B, Buckner TW, Cowell A, Moyer G, Wang M, Gibson E, Mashburn C) Acta Haematol 2021;144(6):672-677 PMID: 33915533 SCOPUS ID: 2-s2.0-85105735444 04/30/2021       1 Citation
  • Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study. (Hart DP, Branchford BR, Hendry S, Ledniczky R, Sidonio RF Jr, Négrier C, Kim M, Rice M, Minshall M, Arcé C, Prince S, Kelleher M, Lee S) Orphanet J Rare Dis 2021 Apr 28;16(1):189 PMID: 33910590 PMCID: PMC8082836 SCOPUS ID: 2-s2.0-85104982126 04/30/2021       16 Citations
  • International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. (van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Goldenberg NA, Holzhauer S, Monagle P, Nowak-Göttl U, Revel-Vilk S, Sciuccatie G, Sirachainan N, Male C, Subcommittee on Pediatric, Neonatal Thrombosis, Hemostasis) J Thromb Haemost 2021 Apr;19(4):1123-1129 PMID: 33792176 PMCID: PMC8252713 SCOPUS ID: 2-s2.0-85103745080 04/02/2021       21 Citations
  • Temporal and anatomic relationship between superficial and deep vein thromboses in hospitalized children. (Doan P, Cox A, Rao E, Branchford B) Thromb Res 2021 Apr;200:30-33 PMID: 33529870 SCOPUS ID: 2-s2.0-85100294168 02/03/2021    
  • Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. (Ross JE, Zhang BM, Lee K, Mohan S, Branchford BR, Bray P, Dugan SN, Freson K, Heller PG, Kahr WHA, Lambert MP, Luchtman-Jones L, Luo M, Perez Botero J, Rondina MT, Ryan G, Westbury S, Bergmeier W, Di Paola J) Blood Adv 2021 Jan 26;5(2):414-431 PMID: 33496739 PMCID: PMC7839359 SCOPUS ID: 2-s2.0-85099863862 01/27/2021       19 Citations
  • Optimizing pharmacologic thromboprophylaxis use in pediatric orthopedic surgical patients through implementation of a perioperative venous thromboembolism risk screening tool. (MacNevin W, Padhye K, Alkhalife Y, Price V, El-Hawary R, Branchford BR, Stevens S, Kulkarni K) Pediatr Blood Cancer 2021 Feb;68(2):e28803 PMID: 33219749 SCOPUS ID: 2-s2.0-85096644082 11/22/2020       2 Citations
  • Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium. (Jaffray J, Branchford B, Goldenberg N, Malvar J, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Sposto R, Ji L, Zakai NA, Faustino EVS, Stillings A, Krava E, Young G, Mahajerin A) J Pediatr 2021 Jan;228:252-259.e1 PMID: 32920105 PMCID: PMC7752847 SCOPUS ID: 2-s2.0-85092213515 09/14/2020       24 Citations
  • New Insights into Platelet Dysfunction in Kawasaki Disease Using a Microfluidic Model of Thrombosis. (Branchford BR, Neeves K) J Pediatr 2020 Nov;226:10-11 PMID: 32795474 SCOPUS ID: 2-s2.0-85090063083 08/17/2020    
  • Hypermethioninemia leads to fatal bleeding and increased mortality in a transgenic I278T mouse model of homocystinuria (Park I, Johnson LK, Cox A, Branchford BR, Di Paola J, Bublil EM, Majtan T) Biomedicines August 2020;8(8) SCOPUS ID: 2-s2.0-85089490113 08/01/2020       5 Citations
  • Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria. (Park I, Johnson LK, Cox A, Branchford BR, Di Paola J, Bublil EM, Majtan T) Biomedicines 2020 Jul 24;8(8) PMID: 32722248 PMCID: PMC7459533 07/30/2020    
  • Accuracy of Bedside Ultrasound Femoral Vein Diameter Measurement by PICU Providers. (Good RJ, Levin M, Feder S, Loi MM, Kim JS, Branchford BR, Czaja AS, Carpenter TC) Pediatr Crit Care Med 2020 Dec;21(12):e1148-e1151 PMID: 32639474 SCOPUS ID: 2-s2.0-85097405427 07/09/2020       7 Citations
  • COVID-19 anticoagulation recommendations in children. (Loi M, Branchford B, Kim J, Self C, Nuss R) Pediatr Blood Cancer 2020 Sep;67(9):e28485 PMID: 32558124 PMCID: PMC7323104 SCOPUS ID: 2-s2.0-85087300158 06/20/2020       60 Citations
  • The phase 3 pediatric anticoagulant era. (Goldenberg NA, Branchford BR) Blood 2020 Feb 13;135(7):459-460 PMID: 32197268 PMCID: PMC7019189 SCOPUS ID: 2-s2.0-85079609163 03/21/2020       5 Citations
  • Glanzmann thrombasthenia: genetic basis and clinical correlates. (Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W, Di Paola J, ClinGen Platelet Disorder Variant Curation Expert Panel) Haematologica 2020 Apr;105(4):888-894 PMID: 32139434 PMCID: PMC7109743 SCOPUS ID: 2-s2.0-85083264534 03/07/2020       74 Citations
  • Prevalence and Risk Factors of Adolescent Venous Thromboembolism (Mahjerin A, Jaffray J, Branchford B) Hematology in the Adolescent Female 1 January 2020:141-152 SCOPUS ID: 2-s2.0-85150536055 01/01/2020    
  • Development of a perioperative venous thromboembolism prophylaxis algorithm for pediatric orthopedic surgical patients. (Padhye K, El-Hawary R, Price V, Stevens S, Branchford B, Kulkarni K) Pediatr Hematol Oncol 2020 Mar;37(2):109-118 PMID: 31868065 SCOPUS ID: 2-s2.0-85077028419 12/24/2019       7 Citations
  • Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism. (Mahajerin A, Jaffray J, Branchford B, Stillings A, Krava E, Young G, Goldenberg NA, Faustino EVS) J Thromb Haemost 2020 Mar;18(3):633-641 PMID: 31808292 SCOPUS ID: 2-s2.0-85076888659 12/07/2019       13 Citations
  • Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy. (Majtan T, Park I, Cox A, Branchford BR, di Paola J, Bublil EM, Kraus JP) FASEB J 2019 Nov;33(11):12477-12486 PMID: 31450979 PMCID: PMC6902697 SCOPUS ID: 2-s2.0-85074378363 08/28/2019       14 Citations
  • Unfractionated heparin dosing requirements in the presence of inflammation during the first six months of life. (Heizer JW, Schardt TQ, Murphy ME, Branchford BR) Thromb Res 2019 May;177:17-22 PMID: 30844684 SCOPUS ID: 2-s2.0-85062225142 03/08/2019       2 Citations
  • Editorial: Pediatric Venous Thromboembolism. (Branchford BR, Jaffray J, Mahajerin A) Front Pediatr 2018;6:269 PMID: 30320050 PMCID: PMC6170657 SCOPUS ID: 2-s2.0-85055814220 10/16/2018       3 Citations
  • Common themes and challenges in hemophilia care: a multinational perspective. (Stoffman J, Andersson NG, Branchford B, Batt K, D'Oiron R, Escuriola Ettingshausen C, Hart DP, Jiménez Yuste V, Kavakli K, Mancuso ME, Nogami K, Ramírez C, Wu R) Hematology 2019 Dec;24(1):39-48 PMID: 30073913 SCOPUS ID: 2-s2.0-85052101534 08/04/2018       12 Citations
  • The Role of Inflammation in Venous Thromboembolism. (Branchford BR, Carpenter SL) Front Pediatr 2018;6:142 PMID: 29876337 PMCID: PMC5974100 SCOPUS ID: 2-s2.0-85048167512 06/08/2018       236 Citations
  • GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis. (Law LA, Graham DK, Di Paola J, Branchford BR) Front Med (Lausanne) 2018;5:137 PMID: 29868590 PMCID: PMC5954114 SCOPUS ID: 2-s2.0-85050084132 06/06/2018       37 Citations
  • Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children. (Branchford BR, Betensky M, Goldenberg NA) Thromb Res 2018 Dec;172:190-193 PMID: 29472108 SCOPUS ID: 2-s2.0-85042173725 02/24/2018       20 Citations
  • Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. (Newall F, Branchford B, Male C) J Thromb Haemost 2018 Feb;16(2):196-208 PMID: 29316202 SCOPUS ID: 2-s2.0-85041006158 01/10/2018       32 Citations
  • A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children's Hospital-Acquired Thrombosis (CHAT) project. (Jaffray J, Mahajerin A, Young G, Goldenberg N, Ji L, Sposto R, Stillings A, Krava E, Branchford B) Thromb Res 2018 Jan;161:67-72 PMID: 29207321 SCOPUS ID: 2-s2.0-85036495249 12/06/2017       59 Citations
  • Risk factors for hospital-associated venous thromboembolism in critically ill children following cardiothoracic surgery or therapeutic cardiac catheterisation. (Atchison CM, Amankwah E, Wilhelm J, Arlikar S, Branchford BR, Stock A, Streiff M, Takemoto C, Ayala I, Everett A, Stapleton G, Jacobs ML, Jacobs JP, Goldenberg NA) Cardiol Young 2018 Feb;28(2):234-242 PMID: 29115202 SCOPUS ID: 2-s2.0-85032828912 11/09/2017       19 Citations
  • The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. (Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, Ng C, Zhang W, Neeves KB, Lentz SR, Wang X, Frye SV, Shelton Earp H 3rd, DeRyckere D, Brass LF, Graham DK, Di Paola JA) J Thromb Haemost 2018 Feb;16(2):352-363 PMID: 29045015 PMCID: PMC5858881 SCOPUS ID: 2-s2.0-85040644454 10/19/2017       22 Citations
  • Recommendations for standardized risk factor definitions in pediatric hospital-acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH. (Branchford BR, Mahajerin A, Raffini L, Chalmers E, van Ommen CH, Chan AKC, Goldenberg NA, Subcommittee on Pediatric/Neonatal Hemostasis and Thrombosis) J Thromb Haemost 2017 Nov;15(11):2274-2278 PMID: 29027741 SCOPUS ID: 2-s2.0-85031422106 10/14/2017       18 Citations
  • Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors. (Knight-Perry J, Branchford BR, Thornhill D, Martiniano SL, Sagel SD, Wang M) Thromb Res 2017 Oct;158:161-166 PMID: 28934665 SCOPUS ID: 2-s2.0-85029534206 09/22/2017       11 Citations
  • Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. (Kastelowitz N, Tamura R, Onasoga A, Stalker TJ, White OR, Brown PN, Brodsky GL, Brass LF, Branchford BR, Di Paola J, Yin H) Sci Rep 2017 Jun 27;7(1):4275 PMID: 28655899 PMCID: PMC5487340 SCOPUS ID: 2-s2.0-85021408036 06/29/2017       13 Citations
  • Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs? (Branchford BR) J Am Heart Assoc 2017 May 17;6(5) PMID: 28515117 PMCID: PMC5524123 SCOPUS ID: 2-s2.0-85019392674 05/19/2017       8 Citations
  • Coagulation Disorders and Cerebrovascular Disease in Children (Bernard TJ, Poisson S, Branchford BR, Nowak-Göttl U) Swaiman's Pediatric Neurology: Principles and Practice: Sixth Edition 11 May 2017:877-882 SCOPUS ID: 2-s2.0-85055069427 05/11/2017    
  • Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements. (Dittmar M, Smith N, Warren B, Clark B, Wathen B, Hammett K, Reiter P, Hilden J, Goldenberg N, Branchford B) Thromb Res 2017 Jun;154:93-95 PMID: 28456027 SCOPUS ID: 2-s2.0-85018750742 04/30/2017       3 Citations
  • The ENTPD1 promoter polymorphism -860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk. (Maloney JP, Branchford BR, Brodsky GL, Cosmic MS, Calabrese DW, Aquilante CL, Maloney KW, Gonzalez JR, Zhang W, Moreau KL, Wiggins KL, Smith NL, Broeckel U, Di Paola J) FASEB J 2017 Jul;31(7):2771-2784 PMID: 28302652 PMCID: PMC6137499 SCOPUS ID: 2-s2.0-85021623731 03/18/2017       6 Citations
  • Clinical and financial impact of HACs: a commentary on clinical and financial costs of hospital-acquired conditions. (Branchford B) Transl Pediatr 2015 Oct;4(4):331-3 PMID: 26835397 PMCID: PMC4728998 02/03/2016    
  • Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. (Branchford BR, Ng CJ, Neeves KB, Di Paola J) Thromb Res 2015 Jul;136(1):13-9 PMID: 26014643 PMCID: PMC4910695 SCOPUS ID: 2-s2.0-84931572021 05/28/2015       62 Citations
  • Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models. (Mahajerin A, Branchford BR, Amankwah EK, Raffini L, Chalmers E, van Ommen CH, Goldenberg NA) Haematologica 2015 Aug;100(8):1045-50 PMID: 26001789 PMCID: PMC5004420 SCOPUS ID: 2-s2.0-84938635037 05/24/2015       115 Citations
  • Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery. (Arlikar SJ, Atchison CM, Amankwah EK, Ayala IA, Barrett LA, Branchford BR, Streiff MB, Takemoto CM, Goldenberg NA) Thromb Res 2015 Oct;136(4):717-22 PMID: 25979250 SCOPUS ID: 2-s2.0-84941877322 05/17/2015       48 Citations
  • Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study. (Atchison CM, Arlikar S, Amankwah E, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA) J Pediatr 2014 Oct;165(4):793-8 PMID: 25064163 PMCID: PMC7269107 SCOPUS ID: 2-s2.0-84908241239 07/30/2014       55 Citations
  • Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit. (Amankwah EK, Atchison CM, Arlikar S, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA) Thromb Res 2014 Aug;134(2):305-9 PMID: 24953982 PMCID: PMC7269108 SCOPUS ID: 2-s2.0-84905101043 06/24/2014       61 Citations
  • Prevention of vte in children (Branchford BR, Raffini L) Pediatric Thrombotic Disorders 1 January 2014:207-218 SCOPUS ID: 2-s2.0-84954233051 01/01/2014    
  • Erratum: Discovery of mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis (Journal of Medicinal Chemistry (2013) 56:23 (9693-9700) DOI: 10.1021/jm4013888) (Zhang W, McIver AL, Stashko MA, Deryckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X) Journal of Medicinal Chemistry August 28, 2014;57(16):7142 SCOPUS ID: 2-s2.0-84906871713 01/01/2014    
  • FVIII/VWF ratio is not a reliable predictor of VWD in children. (Branchford BR, Ruegg K, Villalobos-Menuey E, Jacobson LJ, Di Paola JA, Manco-Johnson M) Pediatr Blood Cancer 2014 May;61(5):936-9 PMID: 24281894 SCOPUS ID: 2-s2.0-84895764326 11/28/2013       4 Citations
  • Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. (Zhang W, McIver AL, Stashko MA, DeRyckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X) J Med Chem 2013 Dec 12;56(23):9693-700 PMID: 24219778 PMCID: PMC3962266 SCOPUS ID: 2-s2.0-84890459446 11/14/2013       42 Citations
  • Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. (Liang X, Branchford B, Greffe B, McGavran L, Carstens B, Meltesen L, Albano EA, Quinones R, Cook B, Graham DK) J Pediatr Hematol Oncol 2013 Jul;35(5):e209-13 PMID: 23619105 SCOPUS ID: 2-s2.0-84880315586 04/27/2013       20 Citations
  • No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation. (Flood VH, Friedman KD, Gill JC, Haberichter SL, Christopherson PA, Branchford BR, Hoffmann RG, Abshire TC, Dunn AL, Di Paola JA, Hoots WK, Brown DL, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR) Blood 2013 May 02;121(18):3742-4 PMID: 23520336 PMCID: PMC3643771 SCOPUS ID: 2-s2.0-84879719268 03/23/2013       29 Citations
  • New developments in the treatment of pediatric hemophilia and bleeding disorders. (Branchford BR, Monahan PE, Di Paola J) Curr Opin Pediatr 2013 Feb;25(1):23-30 PMID: 23274430 SCOPUS ID: 2-s2.0-84873086410 01/01/2013       6 Citations
  • Making a diagnosis of VWD. (Branchford BR, Di Paola J) Hematology Am Soc Hematol Educ Program 2012;2012:161-7 PMID: 23233576 PMCID: PMC5873588 SCOPUS ID: 2-s2.0-84879397042 12/13/2012       25 Citations
  • Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. (Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg NA) Haematologica 2012 Apr;97(4):509-15 PMID: 22133768 PMCID: PMC3347665 SCOPUS ID: 2-s2.0-84859465880 12/03/2011       89 Citations
  • Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research. (Branchford BR, Gibson E, Manco-Johnson MJ, Goldenberg NA) Thromb Res 2012 May;129(5):662-3 PMID: 22104422 SCOPUS ID: 2-s2.0-84860480047 11/23/2011       18 Citations
  • Successful pulmonary artery embolectomy in a patient with a saddle Wilms tumor embolus. (Cooper L, Moore C, Branchford B, Greffe B, Capocelli K, Kuder A, Mehta I, Mourani PM) Pediatr Blood Cancer 2012 May;58(5):806-9 PMID: 21681933 SCOPUS ID: 2-s2.0-84857881778 06/18/2011       4 Citations
  • Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. (Goldenberg NA, Branchford B, Wang M, Ray C Jr, Durham JD, Manco-Johnson MJ) J Vasc Interv Radiol 2011 Feb;22(2):121-32 PMID: 21216157 PMCID: PMC3058325 SCOPUS ID: 2-s2.0-79451473243 01/11/2011       66 Citations
  • Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. (Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Branchford BR, Hoffmann RG, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR) Blood 2010 Jul 15;116(2):280-6 PMID: 20231421 PMCID: PMC2910611 SCOPUS ID: 2-s2.0-77955499972 03/17/2010       140 Citations
  • Last update: 05/13/2024